Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

<< Previous
Bullboard Posts
Next >>
Post by ThatBigGingeron Oct 15, 2020 10:53am
109 Views
Post# 31720934

An interesting opportunity for short term growth

An interesting opportunity for short term growthFeast your eyes on Neutrisci International

Symbol : NU.V

Let me preface this with saying I'm NOT advising you buy, just sharing an option  I have been invested in for 2 years, it's positives and negatives for the short term and why I loaded up recently.

Neutrisci owns proprietary tech for infusing products with THC/CBD which decreases onset time and increases length/consistency of effects. They've also got an energy tablet that is sort of sidelined with the current focus on expansion of their THC/CBD product line.

Short term pros: Recent expansion into Japan with CBD tablets distributed by Tabletz LLC, 5 year distribution deal

Adding dispensaries in California after a long awaited approval process in a stringent state as far as health guidelines

Newly announced expansion into Washington, over 400 dispensaries, multiple SKUs from Cryopharm, and links to Nevada/Michigan/Oklahoma through that deal

Short term cons: Company has a history of getting delayed in approvals processes, so the December launch in Washington could easily be delayed

Corona virus has California on the verge of locking down again, which would impact our product that does well in retail setting

The price has stood strong in the 12.5c-15c range since the japan announcement and products are finally getting on shelves in Japan AND the long awaited California. Its all of these things in the pipeline that lead me to double my position and up my average...

After bouncing back from a near reverse split around the new year, and some private placements diluting the shares outstanding with some pretty fluff news releases, its finally showing signs logically (and TA wise) that its a very good position to take.

Here's the link to the main company's site as well as their partners in both Japan and California.

https://neutrisci.com/

https://tabletz-cbd.com/  - Japanese prodcut 

https://www.cryopharm.com/products/#1566947953721-9622b91b-5572 - Cali/Washington products (all but cafe maria)

Strong believer in helping all ships rise with the tide, so do your own DD, and see you on the NU.V board.
<< Previous
Bullboard Posts
Next >>